Analysis of pituitary adenoma expression patterns suggests a potential role for the NeuroD1 transcription factor in

Lubov Borisovna Mitrofanova1, Olga Mikhailovna Vorobeva1, Andrey Nikolaevich Gorshkov1,2

  • 1Almazov National Medical Research Center, St. Petersburg, Russia.

Oncotarget
|February 6, 2019
PubMed

Insights

NeuroD1 (Neurogenic differentiation 1) is highly expressed in pituitary tumors compared to normal glands. This suggests NeuroD1 is crucial in pituitary adenoma development and a potential target for new therapies.

Area of Science:

  • Endocrinology
  • Molecular Biology
  • Oncology

Background:

  • The role of NeuroD1 in pituitary adenoma pathogenesis is not well understood.
  • Previous studies on NeuroD1 expression patterns in the pituitary have yielded conflicting results.

Purpose of the Study:

  • To investigate the expression patterns of the NeuroD1 transcription factor in various pituitary adenomas and normal adult human pituitary glands.
  • To clarify NeuroD1's role in the biology of the normal pituitary and in the development of pituitary tumors.

Main Methods:

  • Immunohistochemistry was performed on 48 pituitary adenomas and 9 normal pituitary glands.
  • Antibodies against NeuroD1, 6 adenohypophyseal hormones, Ki-67, and CK7 were used.
  • Confocal laser scanning microscopy, electron microscopy, and electron immunocytochemistry were employed for detailed analysis.

Main Results:

  • NeuroD1 expression was detected in all analyzed pituitary adenoma types and normal pituitary glands.
  • The average number of NeuroD1-expressing cells was significantly higher in pituitary adenomas than in normal pituitary tissue (p=0.006).
  • NeuroD1 expression was confirmed across multiple methods in specific tumor types, validating its presence.

Conclusions:

  • NeuroD1 plays a significant role in the pathogenesis of pituitary tumors, irrespective of their hormonal classification.
  • Pituitary adenomas exhibit significantly higher NeuroD1 expression levels compared to normal pituitary glands.
  • NeuroD1 expression did not correlate reliably with studied hormones or Ki-67, indicating its potential as a distinct therapeutic target.

Related Concept Videos

Transcription Factors02:16

Transcription Factors

Tissue-specific transcription factors contribute to diverse cellular functions in mammals. For example, the gene for beta globin, a major component of hemoglobin, is present in all cells of the body. However, it is only expressed in red blood cells because the transcription factors that can bind to the promoter sequences of the beta globin gene are only expressed in these cells. Tissue-specific transcription factors also ensure that mutations in these factors may impair only the function of...
82.7K
Hypothalamic-Pituitary Axis01:37

Hypothalamic-Pituitary Axis

The response to stress—be it physical or psychological, acute or chronic—involves activation of the Hypothalamic-Pituitary-Adrenal (HPA) axis. The HPA axis is part of the neuroendocrine system because it involves both neuronal and hormonal communication. Its function is to regulate homeostatic systems—metabolic, cardiovascular, and immune—providing the necessary means to respond to a stressor.
66.0K
Transcription Elongation Factors02:35

Transcription Elongation Factors

Transcription elongation is a dynamic process that alters depending upon the sequence heterogeneity of the DNA being transcribed. Hence, it is not surprising that the elongation complex's composition also varies along the way while transcribing a gene.
The transcription elongation is regulated via pausing of RNA polymerase on several occasions during transcription. In bacteria, these halts are necessary because the transcription of DNA into mRNA is coupled to the translation of that mRNA...
13.8K
Transcription Elongation Factors02:35

Transcription Elongation Factors

4.8K
General Transcription Factors01:30

General Transcription Factors

Tissue-specific transcription factors contribute to diverse cellular functions in mammals. For example, the gene for beta globin, a major component of hemoglobin, is present in all cells of the body. However, it is only expressed in red blood cells because the transcription factors that can bind to the promoter sequences of the beta globin gene are only expressed in these cells. Tissue-specific transcription factors also ensure that mutations in these factors may impair only the function of...
7.0K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.9K